New trials change management of young patients cryptogenic stroke

Percutaneous device closure of patent foramen ovale (PFO) is coming into favour as a secondary preventive measure in patients with cryptogenic stroke. Writing in the MJA, clinicians from St Vincent’s Hospital Melbourne said evidence for a reduction in recurrent stroke following PFO closure has strengthened in recent years. They said trials such as CLOSE, Gore ...

Already a member?

Login to keep reading.

© 2021 the limbic